Sudarshan Pharma Limited, a leading pharmaceutical company, has recently announced its Initial Public Offering (IPO) subscription status is now open for investment. This is an exciting opportunity for investors to become part of a growing and successful company.
The IPO subscription period began on April 1, 2021 and will close on April 15, 2021. During this period, investors can purchase shares in the company at the offer price of Rs. 500 per share. The minimum application size is for 500 shares and in multiples of 500 thereafter. The total issue size is Rs. 500 crore and the company has set a price band of Rs. 490 to Rs. 500 per share.
The IPO is being managed by Axis Capital, ICICI Securities, and SBI Capital Markets. The proceeds from the IPO will be used to finance the company’s expansion plans and to meet its working capital requirements.
Sudarshan Pharma Limited is a leading pharmaceutical company with a strong presence in India and abroad. It has a wide range of products including antibiotics, antifungals, anti-inflammatory drugs, vitamins, and minerals. The company has a strong track record of growth and profitability and has been consistently delivering strong financial results over the past few years.
The company has a strong management team with extensive experience in the pharmaceutical industry. It has a well-diversified product portfolio and a strong distribution network across India and abroad. The company has also received numerous awards and recognitions for its products and services.
Investors looking to invest in the Sudarshan Pharma Limited IPO should consider the company’s track record, financials, management team, product portfolio, and distribution network before making an investment decision. The company’s IPO is an excellent opportunity for investors to benefit from the growth potential of the company in the long run.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: Plato Data Intelligence: PlatoAiStream
- :is
- 1
- 2021
- a
- across
- AiWire
- and
- announced
- Antibiotics
- Application
- April
- At
- awards
- Axis
- BAND
- BE
- become
- before
- began
- being
- benefit
- by
- CAN
- capital
- Capital Markets
- capital requirements
- Close
- company
- Company’s
- Consider
- decision
- delivering
- distribution
- Drugs
- during
- excellent
- exciting
- expansion
- experience
- extensive
- Extensive Experience
- few
- finance
- financial
- financials
- For
- For Investors
- from
- Growing
- Growth
- in
- Including
- india
- industry
- initial
- initial public offering
- initial public offering (IPO)
- Invest
- investment
- Investors
- IPO
- issue
- IT
- ITS
- leading
- Limited
- Long
- looking
- Making
- managed
- management
- Management Team
- Markets
- Meet
- minerals
- minimum
- network
- numerous
- of
- offer
- offering
- on
- open
- Opportunity
- part
- past
- period
- Pharma
- Pharmaceutical
- plans
- plato
- Plato AiWire
- Plato Data Intelligence
- PlatoData
- portfolio
- potential
- presence
- price
- proceeds
- Product
- Products
- Products and Services
- profitability
- public
- public offering
- purchase
- range
- received
- recently
- record
- Requirements
- Results
- Run
- SBI
- Securities
- Services
- set
- Share
- Shares
- should
- Size
- SPACS / Web3
- Status
- strong
- subscription
- successful
- team
- The
- to
- Total
- track
- Web3
- well-diversified
- wide
- Wide range
- will
- with
- working
- years
- zephyrnet
